Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Allarity Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 14 | 20 | +6 |
| Shares | 950.6K | 1.28M | +330.6K (+34.8%) |
| Value | $1.04M | $1.65M | +$616.0K (+59.5%) |
New holders (8)
Institutions that held Allarity Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Militia Capital Management LLC | 98,978 | $127.7K | 0.02% |
| Citadel Advisors LLC | 91,748 | $118.4K | 0.00% |
| HRT Financial LP | 37,003 | $47.0K | 0.00% |
| Jane Street Group, LLC | 36,021 | $46.5K | 0.00% |
| Susquehanna International Group, LLP | 17,221 | $22.2K | 0.00% |
| Virtu Financial LLC | 15,322 | $20.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,650 | $3.42K | 0.00% |
| FMR LLC | 13 | $17 | 0.00% |
Sold out (2)
Institutions that held Allarity Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Two Sigma Securities, LLC | 12,334 | $13.4K |
| Citigroup Inc | 7,766 | $8.46K |